HLX-97

N/A

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameHLX-97
Drug Alias NameHLX97HLX-97
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone acetyltransferase KAT6A inhibitorsHistone acetyltransferase KAT6B inhibitors
TargetsHistone acetyltransferase KAT6AHistone acetyltransferase KAT6B
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Henlius Biotech Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Fuhong Ruilin Biotechnology Co LtdShanghai Henlius Biologics Co LtdShanghai Henlius Biotech Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A